eMurmur ID vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if you need an immediate, AI-powered decision support tool for detecting and classifying heart murmurs at the point of care or via telehealth. This solution is ideal for clinicians using third-party electronic stethoscopes who require real-time feedback on heart sounds to aid in initial screening and patient management.
View eMurmur ID →Choose LINQ II Insertable Cardiac Monitor if…
Choose the LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring for the diagnosis of infrequent or paroxysmal arrhythmias. This device is best suited for situations demanding prolonged surveillance (up to 4.5 years) with AI-enhanced accuracy and remote management capabilities, particularly when outpatient monitoring has been inconclusive.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Unknown | Enterprise |
| Deployment | Cloud, Mobile, API integration | Hybrid |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID (Tool A) offers real-time feedback and analysis via a mobile app and web portal, integrating directly into a healthcare provider's active workflow for immediate diagnostic support. LINQ II (Tool B), while having a mobile app for data transmission, is an insertable device primarily focused on passive, long-term monitoring, making Tool A more 'usable' for active, on-demand clinical assessment by a provider.
Clinical Value
LINQ II Insertable Cardiac MonitorLINQ II (Tool B) provides long-term, continuous heart rhythm monitoring for up to 4.5 years with advanced AI algorithms (AccuRhythmu2122) for enhanced accuracy in diagnosing elusive arrhythmias, addressing a critical need for conditions that might otherwise be missed. eMurmur ID (Tool A) offers valuable real-time decision support for heart murmur detection and classification, but LINQ II's extended, passive monitoring capability for arrhythmias presents a distinct and high-impact clinical value.
Pricing & Value
TieBoth eMurmur ID (Tool A) and LINQ II (Tool B) have opaque pricing models, requiring direct contact with the vendor or enterprise-level negotiation, and neither publicly discloses specific costs or offers a free trial. Without transparent pricing information, it is impossible to definitively compare their value propositions.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic's LINQ II (Tool B) demonstrates superior enterprise readiness due to Medtronic's long-standing history (founded 1949) and extensive global presence, with over 1 million patients having received a Medtronic ICM worldwide. While eMurmur ID (Tool A) offers flexible deployment options and HIPAA compliance, Medtronic's established infrastructure, proven customer base, and target size from solo to large health systems indicate a more robust and trusted enterprise solution.
Innovation
LINQ II Insertable Cardiac MonitorLINQ II (Tool B) showcases greater innovation with its advanced insertable cardiac monitor, offering up to 4.5 years of continuous monitoring, remote programming, and sophisticated AccuRhythmu2122 AI algorithms for enhanced accuracy in arrhythmia detection, including an innovative PVC detection algorithm. eMurmur ID (Tool A) innovates by bringing AI-powered murmur detection to a mobile and cloud platform with real-time feedback, but LINQ II's long-term, passive, and remotely managed diagnostic capability represents a more significant advancement in cardiac monitoring technology.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic, as a large and established medical device company, provides extensive support resources for LINQ II (Tool B), including detailed clinician and patient manuals, technical services, and patient services. While eMurmur ID (Tool A) is a robust solution, the sheer scale and decades of experience of Medtronic suggest a more comprehensive and structured support and documentation ecosystem for its products.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Name | eMurmur ID | LINQ II Insertable Cardiac Monitor |
| Company | CSD Labs GmbH | Medtronic |
| Tagline | AI-powered & telehealth-enabled | Advanced insertable cardiac monitoring with AI-powered accuracy and remote management. |
| Primary AI Function | AI-based analytics for heart murmur detection and classification | AccuRhythmu2122 AI algorithms for enhanced accuracy |
| Mobile App | Mobile app for recording and displaying heart sounds | MyCareLink Heartu2122 mobile app for data transmission |
| Specialties | Cardiology, Family Medicine, Pediatrics | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and LINQ II Insertable Cardiac Monitor.